{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T14:23:02Z","timestamp":1779200582394,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Assist Reprod Genet"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s10815-025-03555-w","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T04:59:05Z","timestamp":1750913945000},"page":"2737-2746","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Three different protocols for pituitary suppression: progestins (dydrogesterone or medroxyprogesterone acetate) versus GnRH antagonist\u2014balancing efficacy and cost in ovarian stimulation"],"prefix":"10.1007","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0306-6422","authenticated-orcid":false,"given":"P\u0131nar","family":"\u00d6zcan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre Goksan","family":"Pabuccu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ege","family":"Merto\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tun\u00e7","family":"Timur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif Cigdem","family":"Kele\u015f","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilge P\u0131nar","family":"Keskinsoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Recai","family":"Pabu\u00e7\u00e7u","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"issue":"4","key":"3555_CR1","doi-asserted-by":"publisher","first-page":"CD001750","DOI":"10.1002\/14651858.CD001750.pub4","volume":"4","author":"HG Al-Inany","year":"2016","unstructured":"Al-Inany HG, Youssef MA, Ayeleke RO, Brown J, Lam WS, Broekmans FJ. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2016;4(4):CD001750. https:\/\/doi.org\/10.1002\/14651858.CD001750.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"3555_CR2","doi-asserted-by":"publisher","first-page":"CD006919","DOI":"10.1002\/14651858.CD006919.pub4","volume":"2015","author":"CS Siristatidis","year":"2015","unstructured":"Siristatidis CS, Gibreel A, Basios G, Maheshwari A, Bhattacharya S. Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. Cochrane Database Syst Rev. 2015;2015(11):CD006919. https:\/\/doi.org\/10.1002\/14651858.CD006919.pub4.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"3555_CR3","doi-asserted-by":"publisher","first-page":"hoaa009","DOI":"10.1093\/hropen\/hoaa009","volume":"2020","author":"E Bosch","year":"2020","unstructured":"Bosch E, Broer S, Griesinger G, Grynberg M, Humaidan P, Kolibianakis E, et al. ESHRE guideline: ovarian stimulation for IVF\/ICSI. Hum Reprod Open. 2020;2020(2):hoaa009. https:\/\/doi.org\/10.1093\/hropen\/hoaa009.","journal-title":"Hum Reprod Open"},{"issue":"2","key":"3555_CR4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.rbmo.2019.03.212","volume":"39","author":"A La Marca","year":"2019","unstructured":"La Marca A, Capuzzo M. Use of progestins to inhibit spontaneous ovulation during ovarian stimulation: the beginning of a new era? Reprod Biomed Online. 2019;39(2):321\u201331. https:\/\/doi.org\/10.1016\/j.rbmo.2019.03.212.","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"3555_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1093\/humupd\/dmaa040","volume":"27","author":"B Ata","year":"2021","unstructured":"Ata B, Capuzzo M, Turkgeldi E, Yildiz S, La Marca A. Progestins for pituitary suppression during ovarian stimulation for ART: a comprehensive and systematic review including meta-analyses. Hum Reprod Update. 2021;27(1):48\u201366. https:\/\/doi.org\/10.1093\/humupd\/dmaa040.","journal-title":"Hum Reprod Update"},{"key":"3555_CR6","first-page":"378","volume":"1999","author":"DK Gardner","year":"1999","unstructured":"Gardner DK, Schoolcraft WB. In vitro culture of human blastocysts. Towards reproductive certainty: fertility and genetics beyond. 1999;1999:378\u201388.","journal-title":"Towards reproductive certainty: fertility and genetics beyond"},{"issue":"5","key":"3555_CR7","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1093\/humrep\/dez034","volume":"34","author":"R Begueria","year":"2019","unstructured":"Begueria R, Garcia D, Vassena R, Rodriguez A. Medroxyprogesterone acetate versus ganirelix in oocyte donation: a randomized controlled trial. Hum Reprod. 2019;34(5):872\u201380. https:\/\/doi.org\/10.1093\/humrep\/dez034.","journal-title":"Hum Reprod"},{"issue":"3","key":"3555_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/GCO.0000000000000941","volume":"36","author":"J Giles","year":"2024","unstructured":"Giles J, Cruz F, Garcia-Velasco JA. Progestin-primed ovarian stimulation. Curr Opin Obstet Gynecol. 2024;36(3):165\u201372. https:\/\/doi.org\/10.1097\/GCO.0000000000000941.","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"1","key":"3555_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.fertnstert.2015.03.022","volume":"104","author":"Y Kuang","year":"2015","unstructured":"Kuang Y, Chen Q, Fu Y, Wang Y, Hong Q, Lyu Q, et al. Medroxyprogesterone acetate is an effective oral alternative for preventing premature luteinizing hormone surges in women undergoing controlled ovarian hyperstimulation for in vitro fertilization. Fertil Steril. 2015;104(1):62-70 e3. https:\/\/doi.org\/10.1016\/j.fertnstert.2015.03.022.","journal-title":"Fertil Steril."},{"issue":"28","key":"3555_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000004193","volume":"95","author":"X Zhu","year":"2016","unstructured":"Zhu X, Ye H, Fu Y. The Utrogestan and hMG protocol in patients with polycystic ovarian syndrome undergoing controlled ovarian hyperstimulation during IVF\/ICSI treatments. Medicine (Baltimore). 2016;95(28): e4193. https:\/\/doi.org\/10.1097\/MD.0000000000004193.","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"3555_CR11","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1159\/000054656","volume":"73","author":"TA Richter","year":"2001","unstructured":"Richter TA, Robinson JE, Evans NP. Progesterone treatment that either blocks or augments the estradiol-induced gonadotropin-releasing hormone surge is associated with different patterns of hypothalamic neural activation. Neuroendocrinology. 2001;73(6):378\u201386. https:\/\/doi.org\/10.1159\/000054656.","journal-title":"Neuroendocrinology"},{"issue":"3","key":"3555_CR12","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1111\/j.1365-2826.2005.01287.x","volume":"17","author":"TA Richter","year":"2005","unstructured":"Richter TA, Robinson JE, Lozano JM, Evans NP. Progesterone can block the preovulatory gonadotropin-releasing hormone\/luteinising hormone surge in the ewe by a direct inhibitory action on oestradiol-responsive cells within the hypothalamus. J Neuroendocrinol. 2005;17(3):161\u20139. https:\/\/doi.org\/10.1111\/j.1365-2826.2005.01287.x.","journal-title":"J Neuroendocrinol"},{"issue":"4","key":"3555_CR13","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1210\/endo-109-4-1293","volume":"109","author":"L Wildt","year":"1981","unstructured":"Wildt L, Hutchison JS, Marshall G, Pohl CR, Knobil E. On the site of action of progesterone in the blockade of the estradiol-induced gonadotropin discharge in the rhesus monkey. Endocrinology. 1981;109(4):1293\u20134. https:\/\/doi.org\/10.1210\/endo-109-4-1293.","journal-title":"Endocrinology"},{"key":"3555_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2025.104833","author":"M Handa","year":"2025","unstructured":"Handa M, Takiuchi T, Kawaguchi S, Hon C-C, Moody J, Okazaki Y, et al. Adverse effects of progestin-primed ovarian stimulation: combination of clinical study and single cell analysis. Reprod Biomed Online. 2025. https:\/\/doi.org\/10.1016\/j.rbmo.2025.104833.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"3555_CR15","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/s1472-6483(10)60375-6","volume":"15","author":"R Fischer","year":"2007","unstructured":"Fischer R. Understanding the role of LH: myths and facts. Reprod Biomed Online. 2007;15(4):468\u201377. https:\/\/doi.org\/10.1016\/s1472-6483(10)60375-6.","journal-title":"Reprod Biomed Online"},{"issue":"9","key":"3555_CR16","doi-asserted-by":"publisher","first-page":"2404","DOI":"10.1093\/humrep\/dem221","volume":"22","author":"Ziebe S, Lundin K, Janssens R, Helmgaard L, Arce JC, Group M","year":"2007","unstructured":"Ziebe S, Lundin K, Janssens R, Helmgaard L, Arce JC, Group M. Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF. Hum Reprod. 2007;22(9):2404\u201313. https:\/\/doi.org\/10.1093\/humrep\/dem221.","journal-title":"Hum Reprod"},{"issue":"8","key":"3555_CR17","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/humrep\/16.8.1636","volume":"16","author":"J Balasch","year":"2001","unstructured":"Balasch J, Vidal E, Penarrubia J, Casamitjana R, Carmona F, Creus M, et al. Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum Reprod. 2001;16(8):1636\u201343. https:\/\/doi.org\/10.1093\/humrep\/16.8.1636.","journal-title":"Hum Reprod"},{"issue":"4","key":"3555_CR18","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.fertnstert.2011.06.069","volume":"96","author":"AM Propst","year":"2011","unstructured":"Propst AM, Hill MJ, Bates GW, Palumbo M, Van Horne AK, Retzloff MG. Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration. Fertil Steril. 2011;96(4):898\u2013904. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.06.069.","journal-title":"Fertil Steril"},{"issue":"5","key":"3555_CR19","doi-asserted-by":"publisher","first-page":"CD005070","DOI":"10.1002\/14651858.CD005070.pub3","volume":"5","author":"MH Mochtar","year":"2017","unstructured":"Mochtar MH, Danhof NA, Ayeleke RO, Van der Veen F, van Wely M. Recombinant luteinizing hormone (rLH) and recombinant follicle stimulating hormone (rFSH) for ovarian stimulation in IVF\/ICSI cycles. Cochrane Database Syst Rev. 2017;5(5):CD005070. https:\/\/doi.org\/10.1002\/14651858.CD005070.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"3555_CR20","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1016\/s0015-0282(02)03157-6","volume":"77","author":"Z Shoham","year":"2002","unstructured":"Shoham Z. The clinical therapeutic window for luteinizing hormone in controlled ovarian stimulation. Fertil Steril. 2002;77(6):1170\u20137. https:\/\/doi.org\/10.1016\/s0015-0282(02)03157-6.","journal-title":"Fertil Steril"},{"key":"3555_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3389\/fendo.2017.00114","volume":"8","author":"D Santi","year":"2017","unstructured":"Santi D, Casarini L, Alviggi C, Simoni M. Efficacy of follicle-stimulating hormone (FSH) alone, FSH + luteinizing hormone, human menopausal gonadotropin or FSH + human chorionic gonadotropin on assisted reproductive technology outcomes in the \u201cpersonalized\u201d medicine era: a meta-analysis. Front Endocrinol (Lausanne). 2017;8:114. https:\/\/doi.org\/10.3389\/fendo.2017.00114.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3555_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.fertnstert.2024.11.005","volume":"123","author":"JP Toner","year":"2025","unstructured":"Toner JP, Pirtea P. Luteinizing hormone\u2019s critical role in ovarian stimulation. Fertil Steril. 2025;123(1):31\u201340. https:\/\/doi.org\/10.1016\/j.fertnstert.2024.11.005.","journal-title":"Fertil Steril"},{"issue":"3","key":"3555_CR23","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.fertnstert.2010.10.021","volume":"95","author":"E Bosch","year":"2011","unstructured":"Bosch E, Labarta E, Crespo J, Simon C, Remohi J, Pellicer A. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. Fertil Steril. 2011;95(3):1031\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2010.10.021.","journal-title":"Fertil Steril"},{"issue":"4","key":"3555_CR24","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.fertnstert.2005.09.049","volume":"85","author":"F Fabregues","year":"2006","unstructured":"Fabregues F, Creus M, Penarrubia J, Manau D, Vanrell JA, Balasch J. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertil Steril. 2006;85(4):925\u201331. https:\/\/doi.org\/10.1016\/j.fertnstert.2005.09.049.","journal-title":"Fertil Steril"},{"issue":"6","key":"3555_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/s1472-6483(10)61643-4","volume":"8","author":"P Humaidan","year":"2004","unstructured":"Humaidan P, Bungum M, Bungum L, Yding AC. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod Biomed Online. 2004;8(6):635\u201343. https:\/\/doi.org\/10.1016\/s1472-6483(10)61643-4.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"3555_CR26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/s1472-6483(10)60513-5","volume":"8","author":"R Marrs","year":"2004","unstructured":"Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin alfa) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod Biomed Online. 2004;8(2):175\u201382. https:\/\/doi.org\/10.1016\/s1472-6483(10)60513-5.","journal-title":"Reprod Biomed Online"},{"issue":"2","key":"3555_CR27","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1093\/humrep\/dem317","volume":"23","author":"A NyboeAndersen","year":"2008","unstructured":"NyboeAndersen A, Humaidan P, Fried G, Hausken J, Antila L, Bangsboll S, et al. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum Reprod. 2008;23(2):427\u201334. https:\/\/doi.org\/10.1093\/humrep\/dem317.","journal-title":"Hum Reprod"},{"issue":"4","key":"3555_CR28","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/j.rbmo.2022.03.003","volume":"45","author":"L Yang","year":"2022","unstructured":"Yang L, Luo K, Lu G, Lin G, Gong F. Euploidy rates among preimplantation genetic testing for aneuploidy cycles with oral dydrogesterone primed ovarian stimulation or GnRH antagonist protocol. Reprod Biomed Online. 2022;45(4):721\u20136. https:\/\/doi.org\/10.1016\/j.rbmo.2022.03.003.","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"3555_CR29","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.fertnstert.2017.06.017","volume":"108","author":"X Zhu","year":"2017","unstructured":"Zhu X, Ye H, Fu Y. Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization\/intracytoplasmic sperm injection treatments in combination with embryo cryopreservation. Fertil Steril. 2017;108(3):505-12 e2. https:\/\/doi.org\/10.1016\/j.fertnstert.2017.06.017.","journal-title":"Fertil Steril"},{"issue":"4","key":"3555_CR30","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4274\/jtgga.galenos.2020.2020.0110","volume":"22","author":"G DoganDurdag","year":"2021","unstructured":"DoganDurdag G, Bektas G, Turkyilmaz E, Goktepe H, Sonmezer M, Sukur YE, et al. The efficacy of dydrogesterone use to suppress premature luteinizing hormone surge on cycle outcomes in controlled ovarian stimulation. J Turk Ger Gynecol Assoc. 2021;22(4):293\u20139. https:\/\/doi.org\/10.4274\/jtgga.galenos.2020.2020.0110.","journal-title":"J Turk Ger Gynecol Assoc"},{"issue":"2","key":"3555_CR31","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1093\/humrep\/dex367","volume":"33","author":"S Yu","year":"2018","unstructured":"Yu S, Long H, Chang HY, Liu Y, Gao H, Zhu J, et al. New application of dydrogesterone as a part of a progestin-primed ovarian stimulation protocol for IVF: a randomized controlled trial including 516 first IVF\/ICSI cycles. Hum Reprod. 2018;33(2):229\u201337. https:\/\/doi.org\/10.1093\/humrep\/dex367.","journal-title":"Hum Reprod"},{"issue":"1\u20132","key":"3555_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.maturitas.2008.11.013","volume":"61","author":"AE Schindler","year":"2008","unstructured":"Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, et al. Classification and pharmacology of progestins. Maturitas. 2008;61(1\u20132):171\u201380. https:\/\/doi.org\/10.1016\/j.maturitas.2008.11.013.","journal-title":"Maturitas"},{"issue":"Suppl 1","key":"3555_CR33","doi-asserted-by":"publisher","first-page":"S7","DOI":"10.1016\/j.maturitas.2003.09.014","volume":"46","author":"AE Schindler","year":"2003","unstructured":"Schindler AE, Campagnoli C, Druckmann R, Huber J, Pasqualini JR, Schweppe KW, et al. Classification and pharmacology of progestins. Maturitas. 2003;46(Suppl 1):S7\u201316. https:\/\/doi.org\/10.1016\/j.maturitas.2003.09.014.","journal-title":"Maturitas"},{"issue":"2","key":"3555_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1210\/er.2012-1008","volume":"34","author":"FZ Stanczyk","year":"2013","unstructured":"Stanczyk FZ, Hapgood JP, Winer S, Mishell DR Jr. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects. Endocr Rev. 2013;34(2):171\u2013208. https:\/\/doi.org\/10.1210\/er.2012-1008.","journal-title":"Endocr Rev"},{"key":"3555_CR35","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3389\/fendo.2018.00589","volume":"9","author":"C Alviggi","year":"2018","unstructured":"Alviggi C, Conforti A, Esteves SC, Vallone R, Venturella R, Staiano S, et al. Understanding ovarian hypo-response to exogenous gonadotropin in ovarian stimulation and its new proposed marker-the follicle-to-oocyte (FOI) index. Front Endocrinol (Lausanne). 2018;9:589. https:\/\/doi.org\/10.3389\/fendo.2018.00589.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"3555_CR36","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12958-023-01124-3","volume":"21","author":"AH Pai","year":"2023","unstructured":"Pai AH, Sung YJ, Li CJ, Lin CY, Chang CL. Progestin primed ovarian stimulation (PPOS) protocol yields lower euploidy rate in older patients undergoing IVF. Reprod Biol Endocrinol. 2023;21(1):72. https:\/\/doi.org\/10.1186\/s12958-023-01124-3.","journal-title":"Reprod Biol Endocrinol"},{"key":"3555_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.965863","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, Hu Z, Chen Q, Chai W, Cai R, Kuang Y, et al. Neonatal outcomes and congenital malformations in children born after progestin-primed ovarian stimulation protocol. Front Endocrinol (Lausanne). 2022;13: 965863. https:\/\/doi.org\/10.3389\/fendo.2022.965863.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"3555_CR38","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1002\/ijgo.14903","volume":"163","author":"W Zhao","year":"2023","unstructured":"Zhao W, Sun P, Li T, Li Y, Liang X, Li J. Outcomes and cost-effectiveness comparisons of progestin-primed ovarian stimulation, GnRH antagonist protocol, and luteal phase stimulation for fertility preservation. Int J Gynaecol Obstet. 2023;163(2):645\u201350. https:\/\/doi.org\/10.1002\/ijgo.14903.","journal-title":"Int J Gynaecol Obstet"},{"key":"3555_CR39","doi-asserted-by":"publisher","first-page":"CD003414","DOI":"10.1002\/14651858.CD003414.pub2","volume":"1","author":"T Ghobara","year":"2008","unstructured":"Ghobara T, Vandekerckhove P. Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev. 2008;1:CD003414. https:\/\/doi.org\/10.1002\/14651858.CD003414.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"3555_CR40","doi-asserted-by":"publisher","first-page":"CD006359","DOI":"10.1002\/14651858.CD006359.pub3","volume":"10","author":"D Glujovsky","year":"2020","unstructured":"Glujovsky D, Pesce R, Sueldo C, QuinteiroRetamar AM, Hart RJ, Ciapponi A. Endometrial preparation for women undergoing embryo transfer with frozen embryos or embryos derived from donor oocytes. Cochrane Database Syst Rev. 2020;10(10):CD006359. https:\/\/doi.org\/10.1002\/14651858.CD006359.pub3.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"3555_CR41","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/humupd\/dmt030","volume":"19","author":"ER Groenewoud","year":"2013","unstructured":"Groenewoud ER, Cantineau AE, Kollen BJ, Macklon NS, Cohlen BJ. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update. 2013;19(5):458\u201370. https:\/\/doi.org\/10.1093\/humupd\/dmt030.","journal-title":"Hum Reprod Update"},{"issue":"7","key":"3555_CR42","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1093\/humrep\/dew120","volume":"31","author":"ER Groenewoud","year":"2016","unstructured":"Groenewoud ER, Cohlen BJ, Al-Oraiby A, Brinkhuis EA, Broekmans FJ, de Bruin JP, et al. A randomized controlled, non-inferiority trial of modified natural versus artificial cycle for cryo-thawed embryo transfer. Hum Reprod. 2016;31(7):1483\u201392. https:\/\/doi.org\/10.1093\/humrep\/dew120.","journal-title":"Hum Reprod"}],"container-title":["Journal of Assisted Reproduction and Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10815-025-03555-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10815-025-03555-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T11:46:19Z","timestamp":1757504779000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10815-025-03555-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["3555"],"URL":"https:\/\/doi.org\/10.1007\/s10815-025-03555-w","relation":{},"ISSN":["1058-0468","1573-7330"],"issn-type":[{"value":"1058-0468","type":"print"},{"value":"1573-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"assertion":[{"value":"21 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}